COVID-19 may be an occasional Guillain-Barré syndrome trigger
A new paper in Brain, published by Oxford University Press, indicates that a COVID-19 infection may prompt Guillain-Barré syndrome.
Sep 23, 2021
0
223
A new paper in Brain, published by Oxford University Press, indicates that a COVID-19 infection may prompt Guillain-Barré syndrome.
Sep 23, 2021
0
223
Our visual memory system has a phenomenally large capacity. Flick through the image gallery on your phone, or fast forward through a previously watched movie, and notice how the briefly presented images trigger memories with ...
Sep 21, 2021
0
0
A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.
Sep 21, 2021
0
68
Multiple sclerosis (MS) is most often diagnosed between the ages of 20 and 50. Certain genes put a person at greater risk of getting this disease of the central nervous system, but scientists are still trying to understand ...
Sep 7, 2021
0
100
In the nearly 1 million Americans living with multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system—called myelin—is damaged. This slows the transmission of signals from their ...
Aug 24, 2021
0
720
(HealthDay)—A self-directed brain training app may be effective for improving cognitive impairment following mild traumatic brain injury (mTBI), according to a study published online July 27 in Brain.
Aug 13, 2021
0
166
Scientists at the Francis Crick Institute and UCL have studied how proteins accumulate in the wrong parts of brain cells in motor neuron disease, and have demonstrated how it might be possible, in some cases, to reverse this.
Aug 6, 2021
0
848
Consciousness is arguably the most important scientific topic there is. Without consciousness, there would after all be no science. But while we all know what it is like to be conscious—meaning that we have personal awareness ...
Aug 5, 2021
0
586
Riluzole, a drug that has been used for more than 20 years to slow the progression of ALS, commonly known as Lou Gehrig's disease, was shown in a pilot phase 2 study to slow brain metabolic decline and have a positive effect ...
Jul 28, 2021
0
322
Researchers from the £12 million Developing Human Connectome Project have used a novel type of medical imaging to show how different areas of a newborn baby's brain communicate with each other.
Jul 27, 2021
1
688